No four consecutive quarters could be summed for EPS (Diluted); these figures use the latest fiscal year, not a trailing twelve months.
Some figures named '(TTM)' on this payload are the latest FISCAL YEAR, not a trailing twelve months — eps_ttm (fiscal year ended 2025-12-31). No four consecutive quarters could be summed for them — for an IFRS 20-F filer that is every income-statement line (no quarterly income statement is tagged to EDGAR at all); for a US filer it is usually one line the quarterly tagging skips. Each field's own basis is on field_basis.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
154.19×
80.24×
80th
−0.21σ
24.86×
67 · 67
1.0%
1.0%
60th
+0.13σ
−36.9%
127 · 11
0.9%
11.1%
33rd
−0.38σ
−15.4%
115 · 10
1.0%
−0.1%
64th
+0.10σ
−21.3%
139 · 12
14.1%
−6.7%
69th
+0.31σ
5.1%
141 · 141
−22.2%
—
no band (19 mo · 2 distinct)
—
—
8.4%
19 · 2
2.9%
14.4%
3rd
−2.70σ
9.0%
103 · 9
Market Cap
$983.39M
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
Own median 80.24× × $0.16 = $12.84vs the $24.67 close · earnings held constant
Own multiple
P/E
Implied price
vs close
10th percentile
17.96×
$2.87
−88.3%
25th percentile
26.35×
$4.22
−82.9%
median
80.24×
$12.84
−48.0%
75th percentile
151.84×
$24.30
−1.5%
90th percentile
928.25×
$148.52
+502.0%
today
154.19×
$24.67
—
Reference computation · 67 monthly P/E observations in Full · EPS basis FY2025 EPS (Diluted) $0.16 · close $24.67 (2026-08-21)ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Covered pool$978.69B +7.6%/yr 2020→2025Concentration484 of 10,000fragmented · top 3 hold 22.9% · −25 pts since 2020PCRX0.1% · rank 68 of 349 · +0.0pp over 5y· CV 0.17 · σ 0.0pp
Who holds the poolCY2025 · bars scaled to the largest member
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace0.1% → 0.1%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
PCRX share over timelast 6 of 10 published years
Calendar year
2020
2021
2022
2023
2024
2025
Share of covered pool
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
coverage: 322 of the 385 members that…
Share of covered industry revenue · n=349 in Pharmaceuticals & Biotechnology · CY2025 pool · built 2026-08-22 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
